These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Wenk GL Psychopharmacology (Berl); 1989; 99(4):431-8. PubMed ID: 2687922 [TBL] [Abstract][Full Text] [Related]
45. [The importance of in vivo pharmacology in fundamental research on psychotropic drugs and their biological targets]. Costentin J Therapie; 2004; 59(1):51-6. PubMed ID: 15199668 [TBL] [Abstract][Full Text] [Related]
46. Homology in behavioural pharmacology: an approach to animal models of human cognition. Robbins TW Behav Pharmacol; 1998 Nov; 9(7):509-19. PubMed ID: 9862075 [TBL] [Abstract][Full Text] [Related]
48. Challenges for translational psychopharmacology research--some basic principles. Miczek KA; de Wit H Psychopharmacology (Berl); 2008 Aug; 199(3):291-301. PubMed ID: 18523737 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic synergism: How can psychopharmacology improve cognitive rehabilitation? Caixeta L; Caixeta VM Dement Neuropsychol; 2019; 13(4):422-426. PubMed ID: 31844496 [TBL] [Abstract][Full Text] [Related]
50. 'Memory, hither come': Psychopharmacology of memory and more. Young AH J Psychopharmacol; 2021 Jun; 35(6):619-620. PubMed ID: 34039101 [No Abstract] [Full Text] [Related]
51. Continuous avoidance as a base-line for measuring behavioral effects of drugs. HEISE GA; BOFF E Psychopharmacologia; 1962 Oct; 3():264-82. PubMed ID: 13953494 [No Abstract] [Full Text] [Related]
52. The psychopharmacological era: notes toward a history. Healy DT J Psychopharmacol; 1990 Jan; 4(3):152-67. PubMed ID: 22282944 [TBL] [Abstract][Full Text] [Related]
53. The living organism: Strengthening the basis. Cazalis R; Carletti T; Cottam R Biosystems; 2017 Aug; 158():10-16. PubMed ID: 28495292 [TBL] [Abstract][Full Text] [Related]
54. Translational issues with the development of cognition enhancing drugs. Blokland A; van Goethem N; Heckman P; Schreiber R; Prickaerts J Front Neurol; 2014; 5():190. PubMed ID: 25309509 [No Abstract] [Full Text] [Related]
55. Are Animal Models Needed to Discover, Develop and Test Pharmaceutical Drugs for Humans in the 21st Century? Pound P Animals (Basel); 2020 Dec; 10(12):. PubMed ID: 33371480 [TBL] [Abstract][Full Text] [Related]
56. Avoid the hard problem: Employment of mental simulation for prediction is already a crucial step. Schilling M; Cruse H Proc Natl Acad Sci U S A; 2016 Jul; 113(27):E3811. PubMed ID: 27357663 [No Abstract] [Full Text] [Related]
57. Cognition as search. Feldman JA Science; 1991 Feb; 251(4993):575. PubMed ID: 17840870 [No Abstract] [Full Text] [Related]
58. Opioid receptor-mediated control of acetylcholine release in human neocortex tissue. Feuerstein TJ; Gleichauf O; Peckys D; Landwehrmeyer GB; Scheremet R; Jackisch R Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):586-92. PubMed ID: 8938656 [TBL] [Abstract][Full Text] [Related]
59. Psychopharmacological strategies in the search for cognition enhancers. Sanger DJ; Joly D Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417 [TBL] [Abstract][Full Text] [Related]
60. The development of behavioral tests to assess the effects of cognitive enhancers. Olton DS; Wenk L Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():65-9. PubMed ID: 2186416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]